Metabolic syndrome and Framingham risk score for prediction of cardiovascular events in Caribbean Indian patients with blood glucose abnormalities

Diabetes and Metabolism

Volumn 34, Issue 2, 2008, Pages 177-181

  Jaquet, A ^a   Deloumeaux, J ^a,b   Dumoulin, M ^a   Bangou, J ^a,b   Donnet, J P ^a,b   Foucan, L ^a,b  

^a University of Antilles and Guyane   (Guadeloupe)

^b University of Antilles Guyane   (Guadeloupe)

Author keywords

Cardiovascular disease; Caribbean Indians; Framingham risk score; Hyperglycaemia; Metabolic syndrome

Indexed keywords

GLUCOSE;

ADULT; AGE; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; DEATH; FEMALE; FRAMINGHAM RISK SCORE; GENDER; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HOSPITALIZATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INDIAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONPARAMETRIC TEST; PERIPHERAL VASCULAR DISEASE; PROPORTIONAL HAZARDS MODEL; RISK; SCORING SYSTEM; SMOKING; STROKE;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; GUADELOUPE; HUMANS; HYPERGLYCEMIA; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 42449134387     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2007.10.005     Document Type: Article

References (14)

1. Ramachandran A., Snehalatha C., Latha E., Vijay V., and Viswanathan M. Rising prevalence of NIDDM in an urban population in India. Diabetologia 40 (1997) 232-237
2. Costagliola D., Delaunay C., Moutet J.P., Kankambega P., Demeulemeester R., Donnet J.P., et al. The prevalence of diabetes mellitus in the adult population of Guadeloupe as estimated by history or fasting hyperglycaemia. Diabetes Res Clin Pract 12 (1991) 209-216
3. Foucan L., Deloumeaux J., Donnet J.P., Bangou J., Larifla L., Messerchmitt C., et al. Metabolic syndrome components in Indian migrants with type 2 diabetes. A matched comparative study. Diabetes Metab 32 (2006) 337-342
4. D'Agostino Sr. R.B., Grundy S., Sullivan L.M., and Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286 (2001) 180-187
5. Bhopal R., Fischbacher C., Vartiainen E., Unwin N., White M., and Alberti G. Predicted and observed cardiovascular disease in South Asians: application of finrisk, Framingham and Score models to Newcastle heart project data. J Public Health (Oxf) 27 (2005) 93-100
6. Tillin T., Forouhi N., Johnston D.G., McKeigue P.M., Chaturvedi N., and Godsland I.F. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia 48 (2005) 649-656
7. Boullu-Sanchis S., Bangou J., and Dauget M. Estimation de la prévalence du diabète et de l'intolérance au glucose au sein de la communauté indienne de Guadeloupe. Diabetes Metab 24. Suppl. 1 (1998) XXXVIII
8. Third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002;106:3143-421.
9. International Diabetes Federation: the IDF consensus worldwide definition of the metabolic syndrome. [article online], 2005. Available from http://www.idf.org/webdata//docs/metac_syndrome_def.pdf.
10. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
11. Lawlor D.A., Smith G.D., and Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British women's heart and health study. Diabetologia 49 (2006) 41-48
12. Tong P.C., Kong A.P., So W.Y., Yang X., Ho C.S., Ma R.C., et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 30 (2007) 1206-1211
13. Stern M.P., Williams K., Gonzalez-Villalpando C., Hunt K.J., and Haffner S.M. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?. Diabetes Care 27 (2004) 2676-2681
14. Wannamethee S.G., Shaper A.G., Lennon L., and Morris R.W. Metabolic syndrome versus Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165 (2005) 2644-2650